CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 134 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $8,000 | 0.0% | 2,919 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | +166.7% | 2,919 | +317.0% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 700 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -80.0% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | +42.9% | 700 | 0.0% | 0.00% | – |
| Q3 2015 | $7,000 | -58.8% | 700 | 0.0% | 0.00% | – |
| Q2 2015 | $17,000 | -45.2% | 700 | -61.2% | 0.00% | – |
| Q1 2014 | $31,000 | -20.5% | 1,805 | +10.7% | 0.00% | – |
| Q4 2013 | $39,000 | – | 1,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |